Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation

Keyphrases

• Adult Patients 16%
• Apparent Diffusion Coefficient 33%
• Biopsy Planning 16%
• Blood Perfusion 33%
• Brain Tumor 16%
• Capillary Blood 33%
• Cell Packing Density 16%
• Cellularity 16%
• Cerebral Blood Volume 66%
• Clinical Application 16%
• Clinical Value 16%
• Conventional MRI 16%
• Data Quantification 16%
• Diffusion Imaging 100%
• Diffusion Magnetic Resonance Imaging (dMRI) 33%
• Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI) 16%
• Dynamic Susceptibility Contrast 50%
• Edema 16%
• Glial Tissue 16%
• Glioma 100%
• Heterogeneous Tumors 16%
• Hindered Diffusion 50%
• Imaging Data 16%
• Increasing Trends 16%
• Limited Ability 16%
• Microenvironment 16%
• MRI Protocol 16%
• MRI Scan 16%
• Multiple Diffusion 16%
• Multiple Tumors 16%
• Perfusion Fraction 50%
• Primary Brain Tumor 50%
• Sampling Site 16%
• Standard of Care 16%
• Stereotactic Biopsy 16%
• Strong Correlation 16%
• Surgical Resection 16%
• Tissue Edema 16%
• Treatment Evaluation 16%
• Tumor 33%
• Tumor Cell Subpopulations 16%
• Tumor Cells 33%
• Tumor Cellularity 16%
• Tumor Grade 16%
• Tumor Pathology 33%
• Tumor Samples 16%
• Vasculature 16%
• World Health Organization 100%

Medicine and Dentistry

• Biopsy 25%
• Brain Tumor 100%
• Capillary Blood 50%
• Diffusion Imaging 100%
• Diffusion MRI 50%
• Dynamic Susceptibility Contrast 100%
• Edema 50%
• Ganglioglioma 100%
• Grading (Tumors) 25%
• Magnetic Resonance Imaging 50%
• Neoplasm 100%
• Nervous System Cell 25%
• Proteus Syndrome 25%
• Scintigraphy 25%
• Stereotactic Biopsy 25%
• Surgery 25%
• Treatment Planning 25%
• Tumor Cell 75%
• Tumor Pathology 50%
• Vascularity 25%

Biochemistry, Genetics and Molecular Biology

• Apparent Diffusion Coefficient 28%
• Facilitated Diffusion 100%
• Perfusion 85%
• Vascularization 14%